Adrian Senderowicz is Director at PUMA BIOTECHNOLOGY, INC. (PBYI). They have made 5 open-market trades across 2 companies since 2019, most recently 2026-06-12.
CIK 0001616230
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PBYI | SELL · 10b5-1 | 2026-06-12 | 2026-06-15 | $7.20 | $194K | +14.0% | +17.8% | +28.3% |
| PBYI | SELL · 10b5-1 | 2025-06-13 | 2025-06-17 | $3.40 | $92K | +0.9% | -1.2% | +36.5% |
| PBYI | SELL · 10b5-1 | 2024-06-13 | 2024-06-17 | $3.33 | $90K | +2.5% | +14.8% | -20.8% |
| PBYI | SELL · 10b5-1 | 2023-06-13 | 2023-06-15 | $3.45 | $93K | -7.6% | -3.4% | -5.4% |
| PBYI | SELL | 2022-06-16 | 2022-06-21 | $2.63 | $147K | +1.8% | +17.6% | -13.9% |
| PBYI | SELL | 2021-06-11 | 2021-06-15 | $11.17 | $916K | -8.5% | -22.2% | -32.6% |
| PBYI | SELL | 2020-06-11 | 2020-06-15 | $9.89 | $99K | +9.3% | +0.7% | +4.7% |
| CNST | SELL | 2020-05-12 | 2020-05-13 | $50.18 | $939K | -21.4% | -21.8% | -46.6% |
| CNST | SELL | 2019-11-06 | 2019-11-08 | $28.12 | $1.5M | +46.4% | +29.2% | +20.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.